Filing Details
- Accession Number:
- 0001144204-19-023075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-01 19:15:07
- Reporting Period:
- 2019-04-04
- Accepted Time:
- 2019-05-01 19:15:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1625288 | Nexien Biopharma Inc. | NXEN | Pharmaceutical Preparations (2834) | 262049376 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1719804 | Kanativa Usa Inc. | 4340 E. Kentucky Ave. Suite 206 Glendale CO 80246 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-04-04 | 5,000,000 | $0.09 | 19,000,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The Reporting Person sold 5,000,000 shares effective April 4, 2019.
- In exchange for the sale of the 5,000,000 shares of common stock, the Reporting Person received 8,500,000 shares of common stock of Phyto Brands Inc., which valued the shares of Nexien BioPharma Inc. at $0.085 per share.